242 related articles for article (PubMed ID: 29031075)
1. Discovery of new indomethacin-based analogs with potentially selective cyclooxygenase-2 inhibition and observed diminishing to PGE2 activities.
Kassab SE; Khedr MA; Ali HI; Abdalla MM
Eur J Med Chem; 2017 Dec; 141():306-321. PubMed ID: 29031075
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
3. Novel tetrazole-based selective COX-2 inhibitors: Design, synthesis, anti-inflammatory activity, evaluation of PGE
Labib MB; Fayez AM; El-Nahass ES; Awadallah M; Halim PA
Bioorg Chem; 2020 Nov; 104():104308. PubMed ID: 33011534
[TBL] [Abstract][Full Text] [Related]
4. Indomethacin based new triazolothiadiazine derivatives: Synthesis, evaluation of their anticancer effects on T98 human glioma cell line related to COX-2 inhibition and docking studies.
Sever B; Altıntop MD; Kuş G; Özkurt M; Özdemir A; Kaplancıklı ZA
Eur J Med Chem; 2016 May; 113():179-86. PubMed ID: 26927686
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of glycolamide esters of indomethacin as potential cyclooxygenase-2 (COX-2) inhibitors.
Khanna S; Madan M; Vangoori A; Banerjee R; Thaimattam R; Jafar Sadik Basha SK; Ramesh M; Casturi SR; Pal M
Bioorg Med Chem; 2006 Jul; 14(14):4820-33. PubMed ID: 16581252
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of new 4-carboxyl quinoline derivatives as cyclooxygenase-2 inhibitors.
Zarghi A; Ghodsi R; Azizi E; Daraie B; Hedayati M; Dadrass OG
Bioorg Med Chem; 2009 Jul; 17(14):5312-7. PubMed ID: 19560931
[TBL] [Abstract][Full Text] [Related]
7. Ortho-carbaborane derivatives of indomethacin as cyclooxygenase (COX)-2 selective inhibitors.
Scholz M; Blobaum AL; Marnett LJ; Hey-Hawkins E
Bioorg Med Chem; 2012 Aug; 20(15):4830-7. PubMed ID: 22748709
[TBL] [Abstract][Full Text] [Related]
8. New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity.
Farzaneh S; Zeinalzadeh E; Daraei B; Shahhosseini S; Zarghi A
Anticancer Agents Med Chem; 2018; 18(2):295-301. PubMed ID: 28971779
[TBL] [Abstract][Full Text] [Related]
9. myo-Inositol esters of indomethacin as COX-2 inhibitors.
Kadirvel M; Abudalal AS; Rajendran R; Gbaj A; Demonacos C; Freeman S
Carbohydr Res; 2012 Jul; 355():13-8. PubMed ID: 22578527
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, docking simulation, biological evaluations and 3D-QSAR study of 5-Aryl-6-(4-methylsulfonyl)-3-(metylthio)-1,2,4-triazine as selective cyclooxygenase-2 inhibitors.
Irannejad H; Kebriaieezadeh A; Zarghi A; Montazer-Sadegh F; Shafiee A; Assadieskandar A; Amini M
Bioorg Med Chem; 2014 Jan; 22(2):865-73. PubMed ID: 24361187
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological evaluation and docking analysis of 3-methyl-1-phenylchromeno[4,3-c]pyrazol-4(1H)-ones as potential cyclooxygenase-2 (COX-2) inhibitors.
Grover J; Kumar V; Sobhia ME; Jachak SM
Bioorg Med Chem Lett; 2014 Oct; 24(19):4638-4642. PubMed ID: 25219899
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of benzimidazole analogs endowed with oxadiazole as selective COX-2 inhibitor.
Rathore A; Rahman MU; Siddiqui AA; Ali A; Shaharyar M
Arch Pharm (Weinheim); 2014 Dec; 347(12):923-35. PubMed ID: 25303727
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of new 2,3-diarylquinoline derivatives as selective cyclooxygenase-2 inhibitors.
Ghodsi R; Zarghi A; Daraei B; Hedayati M
Bioorg Med Chem; 2010 Feb; 18(3):1029-33. PubMed ID: 20061161
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of novel 1,2-diaryl-4-substituted-benzylidene-5(4H)-imidazolone derivatives as cytotoxic agents and COX-2/LOX inhibitors.
Lamie PF; Philoppes JN; Rárová L
Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700311. PubMed ID: 29400411
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, biological evaluation, and docking studies of some novel chalcones as selective COX-2 inhibitors.
Kaya Çavuşoğlu B; Sağlık BN; Acar Çevik U; Osmaniye D; Levent S; Özkay Y; Kaplancıklı ZA
Arch Pharm (Weinheim); 2021 Mar; 354(3):e2000273. PubMed ID: 33244799
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of new 1,4-diarylazetidin-2-one derivatives (β-lactams) as selective cyclooxygenase-2 inhibitors.
Arefi H; Naderi N; Shemirani ABI; Kiani Falavarjani M; Azami Movahed M; Zarghi A
Arch Pharm (Weinheim); 2020 Mar; 353(3):e1900293. PubMed ID: 31917485
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of novel indanone containing spiroisoxazoline derivatives with selective COX-2 inhibition as anticancer agents.
Abolhasani H; Zarghi A; Komeili Movahhed T; Abolhasani A; Daraei B; Dastmalchi S
Bioorg Med Chem; 2021 Feb; 32():115960. PubMed ID: 33477020
[TBL] [Abstract][Full Text] [Related]
18. New Coumarin Derivatives as Potent Selective COX-2 Inhibitors: Synthesis, Anti-Inflammatory, QSAR, and Molecular Modeling Studies.
Dawood DH; Batran RZ; Farghaly TA; Khedr MA; Abdulla MM
Arch Pharm (Weinheim); 2015 Dec; 348(12):875-88. PubMed ID: 26462142
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a COX-2 selective inhibitor hit with anti-inflammatory activity and gastric ulcer protective effect.
Abdelgawad MA; Bakr RB; El-Gendy AO; Kamel GM; Azouz AA; Bukhari SNA
Future Med Chem; 2017 Oct; 9(16):1899-1912. PubMed ID: 29076755
[TBL] [Abstract][Full Text] [Related]
20. New selective cyclooxygenase-2 inhibitors from cyclocoumarol: Synthesis, characterization, biological evaluation and molecular modeling.
Rayar AM; Lagarde N; Martin F; Blanchard F; Liagre B; Ferroud C; Zagury JF; Montes M; Sylla-Iyarreta Veitía M
Eur J Med Chem; 2018 Feb; 146():577-587. PubMed ID: 29407982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]